Whitehawk Therapeutics, Inc.
WHWK
$1.65
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 21.60M | 27.78M | 25.98M | 25.07M | 23.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.60M | 27.78M | 25.98M | 25.07M | 23.82M |
| Cost of Revenue | 84.30M | 49.36M | 54.05M | 52.61M | 54.40M |
| Gross Profit | -62.70M | -21.58M | -28.07M | -27.54M | -30.58M |
| SG&A Expenses | 36.99M | 38.94M | 36.75M | 36.04M | 40.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 121.29M | 88.30M | 90.80M | 88.66M | 94.48M |
| Operating Income | -99.69M | -60.53M | -64.82M | -63.59M | -70.66M |
| Income Before Tax | -10.42M | 27.61M | -63.69M | -61.69M | -65.44M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.42 | 27.61 | -63.69 | -61.69 | -65.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.42M | 27.61M | -63.69M | -61.69M | -65.44M |
| EBIT | -99.69M | -60.53M | -64.82M | -63.59M | -70.66M |
| EBITDA | -99.52M | -60.33M | -64.63M | -63.40M | -70.47M |
| EPS Basic | -0.06 | 0.16 | -2.36 | -2.29 | -2.43 |
| Normalized Basic EPS | -1.35 | -1.22 | -1.41 | -1.37 | -1.52 |
| EPS Diluted | -0.07 | 0.15 | -2.36 | -2.29 | -2.43 |
| Normalized Diluted EPS | -1.35 | -1.21 | -1.41 | -1.37 | -1.52 |
| Average Basic Shares Outstanding | 162.85M | 120.78M | 108.12M | 108.00M | 107.90M |
| Average Diluted Shares Outstanding | 163.14M | 121.07M | 108.12M | 108.00M | 107.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |